Logo Cellply

Cellply wins an H2020 SME Instrument Phase 1 grant

News

Cellply wins an H2020 SME Instrument Phase 1 grant

Bologna (Italy) – Bruxelles (Belgium), 20 October 2016

Cellply has recently been awarded by the European Commission as winner of a SME Intrsument Phase 1 grant within the Horizon 2020 programme. The ONCOSMART (ONCOlogic patient profiling and personalized treatment through SMART bedside diagnostics) project aims at developing an innovative platform for precision medicine, able to profile each cancer patient by analyzing how one or multiple candidate drugs interact with patient’s cells. The innovative test works by extracting a tumor sample and loading it in the platform readily after sampling, while cells are still alive. The ability of the drug to kill tumor cells is then analyzed and personalized response profiles are created. The platform, consisting of a lab-on-a-chip embedded in disposable cartridge, an analytical instrument and a diagnostic software, provides a result in 24 hours and aims at guiding clinicians in selecting the optimal therapy on a patient-by-patient basis and at supporting drug development companies during clinical development of new drugs. The project will allow Cellply to perform a feasibility study, explore business opportunities and regulatory issues/opportunities, identify a supply chain and set the basis for the development of a new in-vitro diagnostic (IVD) platform.

continue reading

You may also like

Press release

Nature Biotechnology publishes research from DKFZ and Cellply highlighting novel approach for accelerating cellular immunotherapy development

19 March 2024
Events

Dual attendance for Cellply at March’s leading events in the cell therapy industry.

18 March 2024
Events

Launch of VivaCyte® at Advanced Therapies Week 2024

26 January 2024
News

Cellply launches its end-to-end single cell potency characterization platform VivaCyte

17 January 2024
Events

Cellply at Advanced Therapies Week 2024

4 January 2024
Press release

Cellply concludes a new internal round of €3.6 million and extends the round to new investors!

27 September 2023
News

CellPly announces acceptance of one abstract at the CICON23 conference

18 September 2023
Press release

CellPly announces Emiliano Spagnolo as the new CEO

27 July 2023
News

L’innovazione Cellply in un articolo sulla rivista Le Scienze

4 March 2020
Events

Cellply to present new method for evaluating immunotherapy efficacy at the 61th ASH Annual Meeting

25 November 2019
News

Cellply wins the €300k Gaetano Marzotto prize and Unicredit StartLab prize

22 November 2018
Events

Cellply invited to present at the World Health Summit 2019

22 October 2018
Press release

Cellply secures €2.34m non-dilutive grant funding from the European Commission for a novel precision oncology diagnostic platform

24 May 2018
News

Cellply selected as finalist at Lyfebulb Oncology Award

1 March 2018
Events

Cellply abstract accepted at the AACR 2018 Annual Meeting

4 February 2018
Press release

Cellply and Sant’Orsola-Malpighi Polyclinic to present one abstract on AML patient stratification with the Open Microwell platform at the 58th ASH Annual Meeting

4 November 2016
Keep in touch

Need some infos?

Drop us a line or give us a ring. We love to hear from you and are happy to answer any questions.